Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
sesquiterpene/vėžys
Nuoroda įrašoma į mainų sritį
Puslapis 1 nuo 27 rezultatus
Monoterpenes, sesquiterpenes and diterpenes as cancer therapy
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND OF THE INVENTION
Treatment of human cancer is an area of clinical medicine which remains fraught with complications and which often presents an array of suboptimal treatment choices. For example, prostate cancer, which is the most common cancer in men and the second leading cause of
Sesquiterpene derivatives and their use in inflammation or cancer treatment
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
The present invention relates generally to sesquiterpene derivatives, and more specifically to deoxyelephantopin derivatives.
BACKGROUND OF THE INVENTION
The identification and validation of the potential benefits of phytocompounds with low toxicity, but effective for cancer
Use of sesquiterpene lactones for treatment of severe inflammatory disorders
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
This invention pertains to sesquiterpene lactones and sesquiterpene lactone-containing plant extracts and preparations for pharmaceutical uses, particularly the use of sesquiterpene lactones for the treatment of severe inflammatory disorders, for example, sepsis, septic shock, or septicemia.
A large
Monoterpenes and sesquiterpenes as chemotherapeutic and radiation sensitizers and immunomodulators
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
BACKGROUND OF THE INVENTION
The incidence of malignant glioma is approximately 12,000 new cases per year. These tumors represent the second leading cause of cancer mortality in people under the age of 35 and the fourth leading cause in
Methods of inhibition or killing cancer cells using an endoperoxide
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
The present invention relates to the inhibition or killing of cancer cells. More particularly, the present invention relates to the systemic and topical treatments of cancer cells with sesquiterpene compounds.
BACKGROUND OF THE INVENTION
Artemisinin (Qinghaosu) and its analogs
Antrocin containing pharmaceutical compositions for inhibiting cancer cells
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
This invention relates to a method for inhibition of cancer cells, comprising administrating an effective amount of formula I (Sesquiterpene lactones, antrocin) or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier, wherein the
Uses of sesquiterpene lactone compounds and their derivatives in drugs preparation
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND OF THE INVENTION
Technical Field
The present invention belongs to the field of drug technology, specifically relates to the uses of sesquiterpene lactone compounds as the effective components or pharmaceutical composition in preparing drugs, especially the uses in preparing the drugs to
Sesquiterpene derivatives having progesterone receptor binding inhibitory activity
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND OF THE INVENTION
1. Field of Invention
The present invention relates to novel sesquiterpene derivatives as a progesterone receptor binding inhibitor or salts thereof and use of these compounds as pharmaceuticals.
2. Background Art
Surgical endocrinotherapies for breast cancer include
Method for the induction of phase 2 related genes in a mammal comprising administering exemestane
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ELECTRONICALLY
The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Mar. 3, 2017, is named P12589-05_ST25.txt and
Compositions comprising exemestane and novel methods of use
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND OF THE INVENTION
Development of safe and effective agents for reducing the risk of cancer and other chronic diseases is a high priority of contemporary medicine. Implementation of strategies for chemoprevention/chemoprotection is beset with many problems.
In the economically developed
Pharmaceutical compositions comprising monoterpenes
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
The present invention relates to monoterpene or sesquiterpene compositions. In particular, the present invention relates to using monoterpenes (such as (S)-perillyl alcohol) or sesquiterpenes having a purity greater than about 98.5% (w/w) to treat nervous system
Pharmaceutical compositions comprising monoterpenes
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
The present invention relates to monoterpene or sesquiterpene compositions. In particular, the present invention relates to using monoterpenes (such as (S)-perillyl alcohol) or sesquiterpenes having a purity greater than about 98.5% (w/w) to treat nervous system
Pharmaceutical compositions comprising monoterpenes
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
The present invention relates to monoterpene or sesquiterpene compositions. In particular, the present invention relates to using monoterpenes (such as (S)-perillyl alcohol) or sesquiterpenes having a purity greater than about 98.5% (w/w) to treat nervous system
Pharmaceutical compositions comprising monoterpenes
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
The present invention relates to monoterpene or sesquiterpene compositions. In particular, the present invention relates to using monoterpenes (such as (S)-perillyl alcohol) or sesquiterpenes having a purity greater than about 98.5% (w/w) to treat nervous system
Pharmaceutical compositions comprising monoterpenes
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
The present invention relates to monoterpene or sesquiterpene compositions. In particular, the present invention relates to using monoterpenes (such as (S)-perillyl alcohol) or sesquiterpenes having a purity greater than about 98.5% (w/w) to treat nervous system
Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu
- Dirba 55 kalbomis
- Žolelių gydymas, paremtas mokslu
- Vaistažolių atpažinimas pagal vaizdą
- Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
- Skaitykite mokslines publikacijas, susijusias su jūsų paieška
- Ieškokite vaistinių žolelių pagal jų poveikį
- Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus
Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais
